5AM Venture Management, LLC - Q4 2020 holdings

$297 Million is the total value of 5AM Venture Management, LLC's 10 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 11.1% .

 Value Shares↓ Weighting
AKUS SellAKOUOS INC$82,013,000
-22.1%
4,135,784
-10.2%
27.62%
-0.3%
FIXX SellHOMOLOGY MEDICINES INC$51,211,000
-13.5%
4,535,919
-18.1%
17.25%
+10.7%
ARVN SellARVINAS INC$42,465,000
+79.9%
500,000
-50.0%
14.30%
+130.4%
CABA SellCABALETTA BIO INC$42,073,000
+5.8%
3,371,263
-8.1%
14.17%
+35.5%
IDYA SellIDEAYA BIOSCIENCES INC$25,173,000
-42.1%
1,798,066
-48.1%
8.48%
-25.9%
SCPH  SCPHARMACEUTICALS INC$20,268,000
-29.0%
3,831,4740.0%6.83%
-9.1%
CRNX  CRINETICS PHARMACEUTICALS IN$19,222,000
-10.0%
1,362,2860.0%6.47%
+15.3%
APRE SellAPREA THERAPEUTICS INC$6,778,000
-87.3%
1,377,654
-37.7%
2.28%
-83.7%
CDTX  CIDARA THERAPEUTICS INC$4,013,000
-29.8%
2,006,5110.0%1.35%
-10.1%
FVAM New5 01 ACQUISITION CORP$3,713,000365,126
+100.0%
1.25%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HOMOLOGY MEDICINES INC16Q3 202326.6%
ARVINAS INC16Q3 202314.3%
Crinetics Pharmaceuticals, Inc.16Q3 202312.8%
SCPHARMACEUTICALS INC16Q3 20237.5%
CIDARA THERAPEUTICS INC16Q3 20231.7%
IDEAYA BIOSCIENCES INC14Q1 202311.4%
VOR BIOPHARMA INC11Q3 202351.9%
CABALETTA BIO INC11Q2 202214.2%
AKOUOS INC10Q3 202227.7%
IMPEL PHARMACEUTICALS INC10Q3 20237.1%

View 5AM Venture Management, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-03
13F-HR2021-11-15

View 5AM Venture Management, LLC's complete filings history.

Compare quarters

Export 5AM Venture Management, LLC's holdings